Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 4, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • Influenza virus

Tag: Influenza virus

  • BiotechToday
  • World

Nanoworms used to inactivate and kill COVID-19 germs

BioTech Today September 29, 2021September 29, 2021 3

Ananya Ghosal, MAKAUT(WB) The increasing rate of the variants of Coronavirus resulting in an outpouring of diseases in the whole world. The mutation occurring in the spike protein of the virion raise the question of vaccine effectiveness and allows greater transmission. Effective inactivation of the virus is required to prevent the spread of SARS-CoV-2 and […]

Read More
  • BiotechToday
  • World

Diallyl Trisulfide: A potent antiviral against H9N2 Influenza

BioTech Today August 26, 2021August 26, 2021

Shayan Ahmed, Jamia Millia Islamia, New Delhi Influenza is a serious respiratory infection that causes a significant amount of morbidity and mortality. Annually, it is estimated that 290,000–650,000 people die from influenza. There are currently two kinds of anti-influenza virus therapeutic options: M2 channel blockers and neuraminidase inhibitors. However, the clinical utility of these medicines […]

Read More
  • BiotechToday
  • World

Early Response to Influenza Virus in Dendritic Cells

bioxone October 30, 2020October 29, 2020

Thota Kanishka Rao, Amity University Kolkata The influenza infection is related to significant trouble in the human population especially associated with specific danger to kids, the older, and those with certain ailments, for example, pregnancy, obesity, or metabolic disease. Disease with the flu infection triggers a natural immune response pointed toward starting the versatile reaction […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy